Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code:
BSE Limited (S crip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
Pursuant to Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that Dr. Reddy's Laboratories SA, Switzerland,
("DRSA") a wholly-owned subsidiary of the Company, has incorporated a new wholly-owned subsidiary in Denmark, named "Dr.
Reddy's Denmark ApS" on October 4, 2024. Accordingly, Dr. Reddy's Denmark ApS is a step-down wholly-owned subsidiary of the Company.
The details required under Regulation 30 of the
SEBI Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, and SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123
dated July 13, 2023, with respect to the above incorporation of a step down wholly-owned subsidiary is given in Annexure enclosed herewith.
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer &
Disclosure under Part A Para A(i)
of Schedule III read with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
| Sl. No | Particulars | Description |
| 1 | Name of the target entity, details in brief such as size, turnover etc. | Dr . Reddy's Laboratories SA, Switzerland, ("DRSA") a wholly-owned subsidiary of the Company, has incorporated a new wholly-owned subsidiary in Denmark, named "Dr. Reddy's Denmark ApS" on October 4, 2024. Accordingly, Dr. Reddy's Denmark ApS is a step-down wholly-owned subsidiary of the Company. Authorized share capital: DKK 40.000 divided into shares of DKK 1 or multiples thereof. Size/Turnover: Not applicable (yet to commence business operations) |
| 2 | Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arms-length" | Dr. Reddy's Denmark ApS is promoted by DRSA, a Wholly Owned Subsidiary of the Company and therefore is a related party of the Company. |
| 3 | Industry to which the entity being acquired belongs | Pharmaceutical |
| 4 | Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) | Production of any pharmaceutical and biotechnological products, the acquisition, use, purchase and sale of goods of all kinds and in particular of intellectual property rights and activities related hereto. The business of the Dr. Reddy's Denmark ApS is in line with the main line of business of the Company. |
| 5 | Brief details of any governmental or regulatory approvals required for the acquisition | Not Applicable |
| 6 | Indicative time period for completion of the acquisition | Not Applicable |
| 7 | Nature of consideration- whether cash consideration or share swap and details of the same | Subscription of shares by DRSA by way of cash consideration. |
| 8 | Cost of acquisition or the price at which the shares are acquired | DRSA will be paying cash consideration to the Dr. Reddy's Denmark ApS towards subscription of 100% shareholding. |
| 9 | Percentage of shareholding / control acquired and / or number of shares acquired | 100% |